Tweetovi

Blokirali ste korisnika/cu @chasz43

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @chasz43

  1. proslijedio/la je Tweet
    prije 5 sati

    At the with Paul Workman, David Drewry, and Opher Gileadi to kick off the next phase of our chordoma drug discovery project with . This productive team is tackling a tough "undruggable" target. – mjesto: Institute Of Cancer Research

    Poništi
  2. proslijedio/la je Tweet
    7. sij

    “Because of recent research, we have reached this incredible milestone where for the first time we not only have a chance to impact the lives of patients who will come next but actually to change the outcomes for patients who are dealing with today."

    Poništi
  3. proslijedio/la je Tweet
    3. sij

    Some thoughts on current & future challenges in targeted protein degradation, collected by PhD student Alex Hanzl for Current Opinion in Chemical Biology. Part of a special issue on "next generation therapeutics" edited by .

    Poništi
  4. proslijedio/la je Tweet
    17. pro 2019.

    Chordoma patients and family members are just like you! They are young and old, children and parents, friends and colleagues, strong and weak, scared and brave. I promise that all donations, small and large, truly make a difference in their lives.

    Poništi
  5. proslijedio/la je Tweet
    14. kol 2019.

    Patients and their families have the greatest incentive to find cures and much to contribute yet have largely been on the sidelines of research. That is changing, particularly for rare diseases, and, happily, is accelerating the trend with the project.

    Poništi
  6. 27. tra 2019.

    Thank you to the Mainey family and all the alums and current seniors from for today’s Warriors Against Chordoma Hoops Challenge. Raising money for the in honor of Chuck Mainey!

    Poništi
  7. proslijedio/la je Tweet
    25. tra 2019.

    excited to work on this with wonderful collaborators Thank you and for this opportunity to go after the Achilles heel of “yet to be drugged” but we’re coming

    Poništi
  8. proslijedio/la je Tweet
    15. tra 2019.

    ⁩ postulates that chemical biology is key to inventing pharma out of stagnation and high failure rates.

    Poništi
  9. 31. ožu 2019.

    Sending out the bat signal. Any lab alums at ? Tuesday afternoon/evening meetup?

    Poništi
  10. 19. velj 2019.

    Nice to know the boss was listening to all of our Pokémon talk in lab

    Poništi
  11. proslijedio/la je Tweet
    14. velj 2019.

    Roses are red, I thought this gene had target potential, but I checked the dependency score and it was actually a common essential 💔

    Poništi
  12. proslijedio/la je Tweet
    13. velj 2019.

    Check out our lab's latest paper on MMR-mutations as enhancer activators in colon cancer. Couldn't be more pleased with their review process. Special congrats to lead author and MD-PhD student Stevephen Hung. As always, feedback is welcome.

    Poništi
  13. proslijedio/la je Tweet
    12. velj 2019.

    A highly promising new treatment approach for was recently identified by our collaborators What it means and the implications for patients are explained in this recent blog by our co-founder & ED

    Poništi
  14. proslijedio/la je Tweet
    11. velj 2019.
    Odgovor korisniku/ci

    Two answers: 1) Since RNA does pretty much everything, and is involved in all processes, ALL women scientists are actually working on RNA—whether or not they know it. So, them. 2) Joan Steitz.

    Poništi
  15. proslijedio/la je Tweet
    23. sij 2019.

    Great outcome from target discovery partnership with ! In a nutshell: transcriptional CDK inhibitors are a new, indirect way to strike at brachyury - the Achilles heel of chordoma. Nice work from &co

    Poništi
  16. 11. pro 2018.

    Go ! Excited to see myotonic dystrophy research supported by through the very aptly named Ben Barres award.

    Poništi
  17. 3. pro 2018.
    Poništi
  18. 30. stu 2018.

    We're hiring! The lab has open positions in cell line engineering and molecular biology.

    Poništi
  19. proslijedio/la je Tweet
    15. stu 2018.

    Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 - new paper out of Gray lab, Qi lab, and collaborators & Panagiotis A. Konstantinopoulos

    Poništi
  20. proslijedio/la je Tweet
    14. stu 2018.

    Congratulations Dr. Oak! As an homage to your great talk sketches over the years, here’s one for your thesis defense. Fantastic work in the lab and good luck at !

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·